STOCK TITAN

Qiming entities (NASDAQ: ALMR) disclose sizable preferred stakes in Alamar Biosciences

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Alamar Biosciences, Inc. received an initial Form 3 from several Qiming-affiliated investment vehicles reporting indirect ownership of multiple series of preferred stock. These preferred shares are convertible into Class B Common Stock and will automatically convert into common stock upon the closing of the company’s initial public offering pursuant to their terms.

The filing shows holdings of Series A-3, Series A-4, Series B and Series C Preferred Stock, all with a stated conversion feature and no expiration date. Qiming Corporate GP VI, Ltd., Qiming GP VIII, LLC and Qiming GP VIII-HC, LLC may be deemed to have voting and dispositive power over certain positions but each disclaims beneficial ownership beyond its proportionate pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Qiming Managing Directors Fund VI, L.P., Qiming Venture Partners VI, L.P., Qiming GP VIII, LLC, Qiming Venture Partners VIII Investments, LLC, Qiming GP VIII-HC, LLC, Qiming Venture Partners VIII-HC, L.P., Qiming Corporate GP VI, Ltd.
Role null | null | null | null | null | null | null
Type Security Shares Price Value
holding Series A-3 Preferred Stock -- -- --
holding Series A-3 Preferred Stock -- -- --
holding Series A-4 Preferred Stock -- -- --
holding Series A-4 Preferred Stock -- -- --
holding Series B Preferred Stock -- -- --
holding Series B Preferred Stock -- -- --
holding Series C Preferred Stock -- -- --
holding Series C Preferred Stock -- -- --
Holdings After Transaction: Series A-3 Preferred Stock — 71,268 shares (Indirect, See footnote); Series A-4 Preferred Stock — 63,864 shares (Indirect, See footnote); Series B Preferred Stock — 50,031 shares (Indirect, See footnote); Series C Preferred Stock — 1,605,645 shares (Indirect, See footnote)
Footnotes (1)
  1. Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock is convertible into 0.4136 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock have no expiration date. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Each share of Series B Preferred Stock is convertible into 0.4403 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series B Preferred Stock has no expiration date. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
Series C underlying Class B 1,922,329 shares Underlying Class B Common Stock for Series C Preferred Stock, indirect holding
Series C additional underlying Class B 1,605,645 shares Additional underlying Class B Common Stock for Series C Preferred Stock, indirect holding
Series B underlying Class B 1,859,366 shares Underlying Class B Common Stock for Series B Preferred Stock, indirect holding
Series A-4 underlying Class B 2,373,437 shares Underlying Class B Common Stock for Series A-4 Preferred Stock, indirect holding
Series A-3 underlying Class B 2,648,607 shares Underlying Class B Common Stock for Series A-3 Preferred Stock, indirect holding
Conversion ratio A-3/A-4/C 0.4136 share Class B Common Stock per share of Series A-3, A-4 or C Preferred
Conversion ratio Series B 0.4403 share Class B Common Stock per share of Series B Preferred Stock
Series C Preferred Stock financial
"Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock is convertible into 0.4136 share of Class B Common Stock"
A Series C preferred stock is a specific class of ownership issued during a later funding round that gives holders priority over common shareholders for getting paid and receiving dividends, like having a reserved lane in traffic when money is distributed. It often includes agreed rights such as a fixed payout, protection against dilution, and the option to convert into common shares, so investors treat it as a mix of safety and upside potential.
Series B Preferred Stock financial
"Each share of Series B Preferred Stock is convertible into 0.4403 share of Class B Common Stock"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
Class B Common Stock financial
"convertible into 0.4136 share of Class B Common Stock, at the holder's election"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
ten percent owner financial
"reporting persons are flagged as is_ten_percent_owner 1 for their holdings"
beneficial ownership financial
"Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
voting and dispositive power financial
"may be deemed to have voting and dispositive power over the shares held"
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Qiming Managing Directors Fund VI, L.P.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/16/2026
3. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Series A-3 Preferred Stock (1) (1)Class B Common Stock71,268(1)ISee footnote(2)
Series A-3 Preferred Stock (1) (1)Class B Common Stock2,648,607(1)ISee footnote(3)
Series A-4 Preferred Stock (1) (1)Class B Common Stock63,864(1)ISee footnote(2)
Series A-4 Preferred Stock (1) (1)Class B Common Stock2,373,437(1)ISee footnote(3)
Series B Preferred Stock (4) (4)Class B Common Stock50,031(4)ISee footnote(2)
Series B Preferred Stock (4) (4)Class B Common Stock1,859,366(4)ISee footnote(3)
Series C Preferred Stock (1) (1)Class B Common Stock1,605,645(1)ISee footnote(5)
Series C Preferred Stock (1) (1)lass B Common Stock1,922,329(1)ISee footnote(6)
1. Name and Address of Reporting Person*
Qiming Managing Directors Fund VI, L.P.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VI, L.P.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming GP VIII, LLC

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VIII Investments, LLC

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming GP VIII-HC, LLC

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Venture Partners VIII-HC, L.P.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Qiming Corporate GP VI, Ltd.

(Last)(First)(Middle)
C/O MAPLES CORPORATE SERVICES LIMITED
PO BOX 309

(Street)
UGLAND HOUSEGRAND CAYMANKY1-1104

(City)(State)(Zip)

CAYMAN ISLANDS

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock is convertible into 0.4136 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock have no expiration date.
2. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
3. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
4. Each share of Series B Preferred Stock is convertible into 0.4403 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series B Preferred Stock has no expiration date.
5. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
6. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.
Qiming GP VIII, LLC By: /s/ Ho Man LAM/Authorized Signatory04/16/2026
Qiming Venture Partners VIII Investments, LLC By: /s/ Ho Man LAM/Manager04/16/2026
Qiming GP VIII-HC, LLC By: /s/ Ho Man LAM/Authorized Signatory04/16/2026
Qiming Venture Partners VIII-HC, L.P. By: /s/ Ho Man LAM/Authorized Signatory04/16/2026
Qiming Corporate GP VI, Ltd By: /s/ Ho Man LAM/Authorized Signatory04/16/2026
Qiming Managing Directors Fund VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory04/16/2026
Qiming Venture Partners VI, L.P. By: /s/ Ho Man LAM/Authorized Signatory04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Alamar Biosciences (ALMR) Form 3 filing show for Qiming entities?

The Form 3 reports that several Qiming-affiliated funds are ten percent owners, holding multiple series of preferred stock in Alamar Biosciences. These positions are reported as indirect holdings with general partner entities potentially having voting and dispositive power, subject to pecuniary interest disclaimers.

Which preferred stock series do Qiming entities hold in Alamar Biosciences (ALMR)?

Qiming entities report indirect holdings in Series A-3, Series A-4, Series B and Series C Preferred Stock of Alamar Biosciences. Each series is convertible into Class B Common Stock at specified ratios and, under their terms, will automatically convert into common stock upon the company’s initial public offering.

How do Alamar Biosciences (ALMR) preferred shares held by Qiming convert to Class B Common Stock?

Each share of Series A-3, Series A-4 and Series C Preferred Stock converts into 0.4136 share of Class B Common Stock, while each Series B Preferred Stock share converts into 0.4403 share. Conversion can occur at the holder’s election and automatically upon closing of the company’s initial public offering.

Do the preferred stock holdings in Alamar Biosciences (ALMR) have an expiration date?

The footnotes state that the Series A-3, Series A-4, Series B and Series C Preferred Stock reported in the Form 3 have no expiration date. They remain outstanding until converted into Class B Common Stock or automatically into common stock upon the closing of Alamar Biosciences’ initial public offering.

How is beneficial ownership described for Qiming entities in the Alamar Biosciences (ALMR) Form 3?

The filing notes that Qiming Corporate GP VI, Ltd., Qiming GP VIII, LLC and Qiming GP VIII-HC, LLC may be deemed to have voting and dispositive power over certain shares. Each of these general partner entities disclaims beneficial ownership except to the extent of its proportionate pecuniary interest in the reported holdings.

Are the Alamar Biosciences (ALMR) Form 3 holdings direct or indirect for Qiming entities?

All reported positions in the Form 3 are classified as indirect holdings. The shares are held of record by specific Qiming funds or LLCs, with associated general partner entities potentially having voting and dispositive power as described in the footnotes, subject to beneficial ownership disclaimers.